These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20536445)

  • 1. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.
    Matteucci C; Minutolo A; Sinibaldi-Vallebona P; Palamara AT; Rasi G; Mastino A; Garaci E
    Ann N Y Acad Sci; 2010 Apr; 1194():6-19. PubMed ID: 20536445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin alpha1: the regulator of regulators?
    Pierluigi B; D'Angelo C; Fallarino F; Moretti S; Zelante T; Bozza S; De Luca A; Bistoni F; Garaci E; Romani L
    Ann N Y Acad Sci; 2010 Apr; 1194():1-5. PubMed ID: 20536444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin α1: burying secrets in the thymus.
    Moretti S; Oikonomou V; Garaci E; Romani L
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S51-8. PubMed ID: 26098878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.
    Romani L; Bistoni F; Montagnoli C; Gaziano R; Bozza S; Bonifazi P; Zelante T; Moretti S; Rasi G; Garaci E; Puccetti P
    Ann N Y Acad Sci; 2007 Sep; 1112():326-38. PubMed ID: 17495242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin α1 and cancer: action on immune effector and tumor target cells.
    Garaci E; Pica F; Serafino A; Balestrieri E; Matteucci C; Moroni G; Sorrentino R; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P
    Ann N Y Acad Sci; 2012 Oct; 1269():26-33. PubMed ID: 23045967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects.
    Lao X; Li B; Liu M; Shen C; Yu T; Gao X; Zheng H
    Apoptosis; 2015 Oct; 20(10):1307-20. PubMed ID: 26283169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modulation of thymosin alpha 1 in the maturation, differentiation and function of murine bone marrow-derived dendritic cells in the absence or presence of tumor necrosis factor-alpha.
    Huang Y; Chen Z; Zhou C; Yao H; Li M; Xu C
    Int Immunopharmacol; 2004 Apr; 4(4):539-46. PubMed ID: 15099531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal growth inhibition as a bioassay for thymosin alpha1: inactivation of Talpha1 by trifluroacetic acid.
    Bianco-Batlles D; Naylor CW; Moshier JA; Dosescu J; Naylor PH
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):157-60. PubMed ID: 11292250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
    Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
    Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity.
    Matteucci C; Nepravishta R; Argaw-Denboba A; Mandaliti W; Giovinazzo A; Petrone V; Balestrieri E; Sinibaldi-Vallebona P; Pica F; Paci M; Garaci E
    Int Immunopharmacol; 2023 May; 118():110113. PubMed ID: 37028279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
    Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
    Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative and anti-proliferative effects of thymosin alpha1 on cells are associated with manipulation of cellular ROS levels.
    Qin Y; Chen FD; Zhou L; Gong XG; Han QF
    Chem Biol Interact; 2009 Aug; 180(3):383-8. PubMed ID: 19442654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.
    Matteucci C; Minutolo A; Pollicita M; Balestrieri E; Grelli S; D'Ettorre G; Vullo V; Bucci I; Luchini A; Aquaro S; Sinibaldi-Vallebona P; Macchi B; Perno CF; Mastino A; Garaci E
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S83-100. PubMed ID: 26094546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.
    Lao X; Liu M; Chen J; Zheng H
    PLoS One; 2013; 8(8):e72242. PubMed ID: 23977262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
    J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.
    Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C
    Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymosin α1 modifies podosome architecture and promptly stimulates the expression of podosomal markers in mature macrophages.
    Serafino A; Andreola F; Pittaluga E; Krasnowska EK; Nicotera G; Sferrazza G; Sinibaldi Vallebona P; Pierimarchi P; Garaci E
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S101-16. PubMed ID: 26098689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.